These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

621 related articles for article (PubMed ID: 31828974)

  • 1. Hippo-Yap/Taz signaling: Complex network interactions and impact in epithelial cell behavior.
    van Soldt BJ; Cardoso WV
    Wiley Interdiscip Rev Dev Biol; 2020 May; 9(3):e371. PubMed ID: 31828974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Hippo pathway integrates PI3K-Akt signals with mechanical and polarity cues to control tissue growth.
    Borreguero-Muñoz N; Fletcher GC; Aguilar-Aragon M; Elbediwy A; Vincent-Mistiaen ZI; Thompson BJ
    PLoS Biol; 2019 Oct; 17(10):e3000509. PubMed ID: 31613895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation.
    Lin KC; Moroishi T; Meng Z; Jeong HS; Plouffe SW; Sekido Y; Han J; Park HW; Guan KL
    Nat Cell Biol; 2017 Jul; 19(8):996-1002. PubMed ID: 28752853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of transgenic lines to monitor and manipulate Yap/Taz-Tead activity in zebrafish reveals both evolutionarily conserved and divergent functions of the Hippo pathway.
    Miesfeld JB; Link BA
    Mech Dev; 2014 Aug; 133():177-88. PubMed ID: 24560909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic control of YAP and TAZ by the mevalonate pathway.
    Sorrentino G; Ruggeri N; Specchia V; Cordenonsi M; Mano M; Dupont S; Manfrin A; Ingallina E; Sommaggio R; Piazza S; Rosato A; Piccolo S; Del Sal G
    Nat Cell Biol; 2014 Apr; 16(4):357-66. PubMed ID: 24658687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and functional insights into the TEAD-YAP complex in the Hippo signaling pathway.
    Chen L; Loh PG; Song H
    Protein Cell; 2010 Dec; 1(12):1073-83. PubMed ID: 21213102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for Hipk in the Hippo pathway.
    Heidary Arash E; Attisano L
    Sci Signal; 2013 May; 6(275):pe18. PubMed ID: 23674821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease implications of the Hippo/YAP pathway.
    Plouffe SW; Hong AW; Guan KL
    Trends Mol Med; 2015 Apr; 21(4):212-22. PubMed ID: 25702974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway.
    Zhang J; Ji JY; Yu M; Overholtzer M; Smolen GA; Wang R; Brugge JS; Dyson NJ; Haber DA
    Nat Cell Biol; 2009 Dec; 11(12):1444-50. PubMed ID: 19935651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reciprocal regulation of YAP/TAZ by the Hippo pathway and the Small GTPase pathway.
    Jang JW; Kim MK; Bae SC
    Small GTPases; 2020 Jul; 11(4):280-288. PubMed ID: 29457552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells.
    Van Sciver N; Ohashi M; Pauly NP; Bristol JA; Nelson SE; Johannsen EC; Kenney SC
    PLoS Pathog; 2021 Aug; 17(8):e1009783. PubMed ID: 34339458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposing transcriptional and post-transcriptional roles for Scalloped in binary Hippo-dependent neural fate decisions.
    Xie B; Morton DB; Cook TA
    Dev Biol; 2019 Nov; 455(1):51-59. PubMed ID: 31265830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
    Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
    J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanical strain regulates the Hippo pathway in
    Fletcher GC; Diaz-de-la-Loza MD; Borreguero-Muñoz N; Holder M; Aguilar-Aragon M; Thompson BJ
    Development; 2018 Mar; 145(5):. PubMed ID: 29440303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippo effector, Yorkie, is a tumor suppressor in select
    Bhattacharya R; Kumari J; Banerjee S; Tripathi J; Parihar SS; Mohan N; Sinha P
    Proc Natl Acad Sci U S A; 2024 Sep; 121(39):e2319666121. PubMed ID: 39288176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippo pathway effectors YAP, TAZ and TEAD are associated with EMT master regulators ZEB, Snail and with aggressive phenotype in phyllodes breast tumors.
    Akrida I; Makrygianni M; Nikou S; Mulita F; Bravou V; Papadaki H
    Pathol Res Pract; 2024 Oct; 262():155551. PubMed ID: 39153238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-hippo kinases: indispensable roles in YAP/TAZ signaling and implications in cancer therapy.
    Zhu J; Wu T; Lin Q
    Mol Biol Rep; 2023 May; 50(5):4565-4578. PubMed ID: 36877351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Hippo size control pathway--ever expanding.
    Lin JI; Poon CL; Harvey KF
    Sci Signal; 2013 Jan; 6(259):pe4. PubMed ID: 23354686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic Fluctuations in Subcellular Localization of the Hippo Pathway Effector Yorkie In Vivo.
    Manning SA; Dent LG; Kondo S; Zhao ZW; Plachta N; Harvey KF
    Curr Biol; 2018 May; 28(10):1651-1660.e4. PubMed ID: 29754899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yap and Taz regulate retinal pigment epithelial cell fate.
    Miesfeld JB; Gestri G; Clark BS; Flinn MA; Poole RJ; Bader JR; Besharse JC; Wilson SW; Link BA
    Development; 2015 Sep; 142(17):3021-32. PubMed ID: 26209646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.